Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma - 10/10/20
Doi : 10.1016/j.jaad.2020.04.186
Michael A. Marchetti, MD a, ⁎ 
, Stephen W. Dusza, DrPH a, Edmund K. Bartlett, MD b
, Stephen W. Dusza, DrPH a, Edmund K. Bartlett, MD b a Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
b Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
∗Reprint requests: Michael A. Marchetti, MD, Dermatology Service, Memorial Sloan Kettering Cancer Center, 545 E 73rd St, New York, NY, 10021Dermatology ServiceMemorial Sloan Kettering Cancer Center545 E 73rd StNew YorkNY10021
El texto completo de este artículo está disponible en PDF.
| Funding source: Supported in part by a grant from the National Cancer Institute/National Institutes of Health (P30-CA008748). |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
© 2020
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 83 - N° 5
P. e357-e358 - novembre 2020 Regresar al número
Artículo precedente
- Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss
- Diego Fernandez-Nieto, David Saceda-Corralo, Juan Jimenez-Cauhe, Oscar Muñoz Moreno-Arrones, Rita Rodrigues-Barata, Angela Hermosa-Gelbard, Sergio Vano-Galvan
- Reply to Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma
- Bradley N. Greenhaw, Kyle R. Covington, Sarah J. Kurley, Yildiray Yeniay, Nhat Anh Cao, Kristen M. Plasseraud, Robert W. Cook, Eddy C. Hsueh, Brian R. Gastman, Maria L. Wei
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?